Cargando…
The Impact of COVID‐19 on the Initiation of Clinical Trials in Europe and the United States
The coronavirus disease 2019 (COVID‐19) pandemic has a major impact not only on public health and daily living, but also on clinical trials worldwide. To investigate the potential impact of the COVID‐19 pandemic on the initiation of clinical trials, we have descriptively analyzed the longitudinal ch...
Autores principales: | Lasch, Florian, Psarelli, Eftychia‐Eirini, Herold, Ralf, Mattsson, Andrea, Guizzaro, Lorenzo, Pétavy, Frank, Schiel, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015398/ https://www.ncbi.nlm.nih.gov/pubmed/35090044 http://dx.doi.org/10.1002/cpt.2534 |
Ejemplares similares
-
Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand
por: Pétavy, Frank, et al.
Publicado: (2020) -
Potential impact of COVID‐19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA‐TICS study
por: Lasch, Florian, et al.
Publicado: (2021) -
Clinical development of nitisinone for alkaptonuria (developakure) - a rare disease clinical trials design
por: Psarelli, Eftychia Eirini, et al.
Publicado: (2013) -
Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial
por: Rai, Zainab L, et al.
Publicado: (2022) -
Ascertaining the initiation of epidemic resurgences: an application to the COVID-19 second surges in Europe and the Northeast United States
por: Vilar, Jose M. G., et al.
Publicado: (2021)